Evidence map›Paper›PMID 41898786›Full record

ArticleGenes2026

Bianca Kruger, Emile Chimusa, Aron Abera, Jesmika Singh, Delva Shamley, Collet Dandara

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Genetic Variation inJournal of personalized medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bianca KrugerPlatform for Pharmacogenomics Research and Translation (PREMED), South African Medical Research Council, Cape Town 7700, South Africa.ORCID 0000-0003-1027-6660
Emile ChimusaBioinformatic and Multi-Omics Data Science Group, Faculty of Science and Environment, Northumbria University, Newcastle NE1 8ST, UK.ORCID 0000-0001-8846-2047
Aron AberaInqaba Biotechnical Industries, Pretoria 0002, South Africa.
Jesmika SinghPlatform for Pharmacogenomics Research and Translation (PREMED), South African Medical Research Council, Cape Town 7700, South Africa.
Delva ShamleyDivision of Clinical Anatomy and Biological Anthropology, Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Cape Town 7700, South Africa.ORCID 0000-0003-2355-6629
Collet DandaraPlatform for Pharmacogenomics Research and Translation (PREMED), South African Medical Research Council, Cape Town 7700, South Africa.ORCID 0000-0002-5925-4895

Funding

South African Medical Research Council EMU grant
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Agents, HormonalArylsulfotransferaseBreast NeoplasmsDrug-Related Side Effects and Adverse ReactionsGlucuronosyltransferaseTamoxifenAdultFemaleHumansMiddle AgedPolymorphism, Single NucleotideSouth AfricaSouthern African PeopleAntineoplastic Agents, HormonalArylsulfotransferaseGlucuronosyltransferaseTamoxifenAfricabreast cancerpharmacogeneticsside effectssulfotransferasestamoxifenUDP-glucuronosyltransferases

Identifiers

PMID41898786
PMCPMC13025226

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.